An evaluation of leukaemia inhibitory factor as a potential therapeutic agent in the treatment of muscle disease

Neuromuscular Disorders

Volumn 12, Issue 10, 2002, Pages 909-916

  White, Jason D ^a   Davies, Marilyn ^a   McGeachie, John ^a   Grounds, Miranda D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Extracellular matrix; Leukaemia inhibitory factor; Skeletal muscle regeneration

Indexed keywords

ALGINIC ACID; EVANS BLUE; LEUKEMIA INHIBITORY FACTOR; GROWTH INHIBITOR; INTERLEUKIN 6; LIF PROTEIN, MOUSE; LYMPHOKINE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CELL DAMAGE; CELL PROLIFERATION; CONTROLLED STUDY; DIAPHRAGM; DRUG DELIVERY SYSTEM; DRUG RELEASE; HISTOPATHOLOGY; MORPHOMETRICS; MOUSE; MUSCLE DISEASE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL SIZE; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; MUSCLE CELL; PATHOPHYSIOLOGY; RADIOGRAPHY; REGENERATION; STATISTICAL ANALYSIS; TRANSPLANTATION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; AUTORADIOGRAPHY; CELL SIZE; DIAPHRAGM; DISEASE MODELS, ANIMAL; GROWTH INHIBITORS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MATCHED-PAIR ANALYSIS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE FIBERS; MUSCULAR DISEASES; RECOMBINANT PROTEINS; REGENERATION;

EID: 0036896446     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(02)00117-7     Document Type: Article

References (37)

1. Grounds M.D. Towards understanding skeletal muscle regeneration. Pathol Res Pract. 187:1991;1-22.
2. Thaloor D., Miller K., Gephart J., Mitchell P.O., Pavlath G.K. Systemic administration of the NF-kB inhibitor curcumin stimulates muscle regeneration after traumatic injury. Am J Physiol. 277:1999;C320-C329.
3. DeRosimo J.F., Washabaugh C.H., Ontell M.P., et al. Enhancement of adult muscle regeneration by primary myoblast transplantation (in process citation). Cell Transplant. 9:2000;369-377.
4. Barnard W., Bower J., Brown M.A., Murphy M., Austin L. Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle expresses LIF mRNA. J Neurol Sci. 123:1994;108-113.
5. Kurek J.B., Nouri S., Kannourakis G., Murphy M., Austin L. Leukaemia inhibitory factor and interlukin-6 are produced in diseased and regenerating skeletal muscle. Muscle Nerve. 19:1996;1291-1301.
6. Kurek J.B., Bower J., Romanella M., Austin L. Leukaemia inhibitory factor treatment stimulates muscle regeneration in the mdx mouse. Neurosci Lett. 212:1996;167-170.
7. Kurek J.B., Bower J., Romanella M., Kontgen F., Murphy M., Austin L. The role of leukaemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve. 20:1997;815-822.
8. Austin L., Burgess A.W. Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor and other cytokines. J Neurol Sci. 101:1991;193-197.
9. Austin L., Bower J., Kurek J., Vakakis N. Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. J Neurol Sci. 112:1992;185-191.
10. Vakakis N., Bower J., Austin L. In vitro myoblast to myotube transformations in the presence of leukemia inhibitory factor. Neurochem Int. 27:1995;29-35.
11. Lefaucheur J.P., Sebille A. Basic fibroblast growth factor promotes in vivo muscle regeneration in murine muscular dystrophy. Neurosci Lett. 202:1995;121-124.
12. Menetrey J., Kasemkijwattana C., Day C.S., et al. Growth factors improve muscle healing in vivo. J Bone Joint Surg Am. 82:2000;131-137.
13. Miller K.J., Thaloor D., Matteson S., Pavlath G.K. Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle. Am J Cell Physiol. 278:2000;C174-C181.
14. Grounds M.D. Muscle regeneration: molecular aspects and therapeutic implications. Curr Opin Neurol. 12:1999;535-543.
15. McGeachie J.K., Grounds M.D. The timing between skeletal muscle myoblast replication and fusion into myotubes, and the stability of regenerated dystrophic myofibres: an autoradiographic study in mdx mice. J Anat. 194:1999;287-295.
16. Bulfield G., Siller W.G., Wright P.A.L., Moore K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA. 81:1984;1189-1192.
17. Partridge T.A. Models of dystrophinopathy, pathological mechanisms and assessment of therapies. Brown S.C., Lucy J.A. Dystrophin: gene, protein and cell biology. 1997;310-331 Cambridge University Press, Cambridge, MA.
18. Brussee V., Merly F., Tardif F., Tremblay J.P. Normal myoblast implantation in MDX mice prevents muscle damage by exercise. Biochem Biophys Res Commun. 250:1998;321-327.
19. Brussee V., Tardif F., Tremblay J.P. Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul Disord. 7:1997;487-492.
20. Stedman H.H., Sweeny H.L., Shrager J.B., et al. The MDX mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature. 352:1991;536-538.
21. Austin L., Bower J.J., Bennett T.M., et al. Leukaemia inhibitory factor (LIF) ameliorates muscle fiber degeneration in the mdx mouse. Muscle Nerve. 23:2000;1700-1705.
22. White J.D., Davies M.D., Grounds M.D. Leukaemia inhibitory factor increases myoblast replication and survival and affects extracellular matrix production: combined in vivo and in vitro studies in post-natal skeletal muscle. Cell Tissue Res. 306:2001;129-141.
23. Burkin D.J., Kaufman S.J. The alpha 7 beta 1 integrin in muscle development and disease. Cell Tissue Res. 296:1999;183-190.
24. Anderson J.E., Vargas C., Weber M. Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy. Cell Transplant. 9:2000;551-564.
25. Straub V., Rafael J.A., Chamberlain J.S., Campbell K.P. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol. 139:1997;375-385.
26. Matsuda R., Nishikawa A., Tanaka H. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem. 118:1995;959-964.
27. Tidball J.G., Berchenko E., Frenette J. Macrophage invasion does not contribute to muscle membrane injury during inflammation. J Leukoc Biol. 65:1999;192-198.
28. Hamer P.W., McGeachie J.M., Davies M.J., Grounds M.D. Evans blue dye used as an in vivo marker of myofibre fragility and damage in mice: defining optimal parameters. J Anat. 200:2002;69-79.
29. Austin L., Bower J.J., Kurek J.B., Muldoon C.M. Controlled release of leukaemia inhibitory factor (LIF) to tissues. Growth Factors. 15:1997;61-68.
30. McGeachie J.K., Grounds M.D. Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice. Cell Tissue Res. 248:1987;125-130.
31. Grounds M.D., McGeachie J.K. A comparison of muscle precursor replication in crush-injured skeletal muscle of Swiss and Balbc mice. Cell Tissue Res. 255:1989;385-391.
32. Beilharz M.W., Lareu R.R., Garrett K.L., Grounds M.D., Fletcher S. Quantitation of muscle precursor cell activity in skeletal muscle by northern analysis of MyoD and myogenin expression - Application to dystrophic (mdx) mouse muscle. Mol Cell Neurosci. 3:1992;326-331.
33. McGeachie J.K., Grounds M.D., Partridge T.A., Morgan J.E. Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies. J Neurol Sci. 119:1993;169-179.
34. White J.D., Bower J.J., Kurek J.B., Austin L. Leukemia inhibitory factor enhances regeneration in skeletal muscles after myoblast transplantation. Muscle Nerve. 24:2001;695-697.
35. Dubowitz V. Therapeutic possibilities in muscular dystrophy: the hope versus the hype. Neuromuscul Disord. 12:2002;113-116.
36. Gregorevic P., Hayes A., Lynch G.S., Williams D.A. Functional properties of regenerating skeletal muscle following LIF administration. Muscle Nerve. 23:2000;1586-1588.
37. Gregorevic P., Williams D.A., Lynch G.S. Effects of leukemia inhibitory factor on rat skeletal muscles are modulated by clenbuterol. Muscle Nerve. 25:2002;194-201.